<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="2332">
<titleInfo>
<title>Asian Journal of Pharmaceutical Sciences Volume 18, Issue 5 2023</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text">China</placeTerm></place>
<publisher>China Medical University</publisher>
<dateIssued>2023</dateIssued>
<issuance>monographic</issuance>
<edition>Volume 18, Issue 5 2023</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Jurnal</form>
<extent></extent>
</physicalDescription>
<note>a b s t r a c t
RNA interference (RNAi) using small interfering RNA (siRNA) has shown potential as a
therapeutic option for the treatment of arthritis by silencing specific genes. However, siRNA
delivery faces several challenges, including stability, targeting, off-target effects, endosomal
escape, immune response activation, intravascular degradation, and renal clearance. A
variety of nanotherapeutics like lipidic nanoparticles, liposomes, polymeric nanoparticles,
and solid lipid nanoparticles have been developed to improve siRNA cellular uptake,
protect it from degradation, and enhance its therapeutic efficacy. Researchers are also
investigating chemical modifications and bioconjugation to reduce its immunogenicity.
This review discusses the potential of siRNA nanotherapeutics as a therapeutic option
for various immune-mediated diseases, including rheumatoid arthritis, osteoarthritis,
etc. siRNA nanotherapeutics have shown an upsurge of interest and the future looks
promising for such interdisciplinary approach-based modalities that combine the principles of molecular biology, nanotechnology, and formulation sciences.</note>
<subject authority=""><topic>Osteoarthritis</topic></subject>
<subject authority=""><topic>Nanotherapeutics</topic></subject>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0116</numerationAndChronology>
<sublocation>Perpus.Akfarsam (Jurnal Farmasi Internasional)</sublocation>
<shelfLocator>615 ASI</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="2205" url="https://drive.google.com/file/d/1La3kkdD3VRlP0xP3N_kM7NzYesjONcUu/view?usp=sharing" path="/https://drive.google.com/file/d/1La3kkdD3VRlP0xP3N_kM7NzYesjONcUu/view?usp=sharing" mimetype="text/uri-list">Volume 18, Issue 5 2023</slims:digital_item>
</slims:digitals><slims:image>Volume_18%2C_Issue_5.jpeg.jpeg</slims:image>
<recordInfo>
<recordIdentifier>2332</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2026-07-10 08:10:40</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2026-07-10 09:10:26</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>